| |
| Active Pharmaceutical Ingredients |
|
| FL-3087084
Alfacalcidol |
[41294-56-8]
(1α,3β,5Z,7E)-9, 10-
Secocholesta-5,7,10 (19)-
triene-1,3-diol, EP grade
C27H44O2
FW 400.6
Use: Calcium regulator
Specification
|
|
|
| |
| FL-3089253
Apraclonidine hydrochloride |
[73218-79-8]
2-[(4-Amino-2,6-dichlorophenyl)imino]imidazo-
lidine monohydrochloride, USP grade
C9H10Cl2N4O
. HCl
FW 281.57
Use: Adrenergic α2-agonist
Specification
|
 |
|
|
| FL-3087049
Balsalazide Disodium |
[150399-21-6]
(E)-5-[[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]azo]-
2-hydroxybenzoic acid, disodium salt, dihydrate
C17H13N3Na2O6
. 2H2O
FW 437.31
Use: Agent against ulcerative colitis
Specification
|
 |
|
|
| FL-3092411
Benzonatate |
[104-31-4]
Benzoic acid , 4-(butylamino)-,2,5,8,11,14,17,20,23,26-nonaoxaoctacos-28-yl
ester 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl p
-(butylamino)-benzoate
C30H53NO11
FW:603.00
Use: Symptomatic relief of cough
Specification
|
 |
|
|
| FL-3087073
Calcitriol |
[32222-06-3]
(1α,3β,5Z,7E)-9, 10-Secocholesta-
5, 7, 10 (19)-triene-1, 3, 25-triol, EP grade
C27H44O3
FW 416.65
Use: Calcium regulator, Anti-psoriatic
Specification
|
 |
|
|
| FL-3091321
Calcipotriol |
[112965-21-6]
24-cyclopropyl-(1α,3β,5Z,7E,22E,24S)- 9, 10-Secochola-5,
7, 10 (19), 22-tetraene-
1, 3, 24-triol; Calcipotriene
C27H40O3
FW 412.62
Use: Anti-psoriatic
Specification |
 |
|
|
| FL-3087051
Capsaicin |
|
[404-86-4]
(E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
C18H27NO3
FW 305.42
Use: Topical analgesic (for neuralgia)
Specification
|
 |
|
|
| FL-3091376
Colestipol HCI |
|
[37296-80-3]
a copolymer of diethylenetramine and 1-chloro-2,3-epoxypropane
with approximately one out of five amino nitrogens protonated
Use: Cholesterol-lowering agent
Specification
|
|
|
|
| FL-3087027
Fludiazepam |
[3900-31-0]
7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-
1-methyl-2H-1,4-benzodiazepin-2-one,
JP grade
C16H12ClFN2O
FW 302.7
Use: Anxiolytic, Sedative
Specification
|
 |
|
|
| FL-3091332
Flupentixol dihydrochloride |
[2413-38-9]
2-[4-[3-(E,Z)-2-(trifluoromethyl)-9H-
thioxanthen-9-ylidene]propyl]piperazin-
1-yl]-ethanol dihydrochloride
EP grade
C23H27Cl2F3N2OS
. 2HCl
FW 507.4
Use: Antipsychotic
Specification
|
 |
|
|
| FL-3093477
Flupentixol decanoate |
[30909-51-4]
Use: Antipsychotic
Specification |
 |
|
|
|
FL-3093466 Glycopyrrolate |
[596-51-0]
Use: Anti-cholinergic for the treatment of ulcers
Specification
|  |
|
| FL-3087038
Leflunomide |
[75706-12-6]
α,α,α-Trifluoro-5-methyl-4-
isoxazolecarboxy-p-toluidide,
C12H9F3N2O2
FW 270.21
Use: Disease-modifying anti-rheumatic drug
Specification
|
 |
|
|
| FL-3091343
Melitracen hydrochloride |
[5118-29-6]
3-(10,10-Dimethyl-9(10H)-anthracenylidene)-
N, N-dimethyl-1-propanamine hydrochloride
C21H25N
. HCl
FW 327.89
Use: Antipsychotic
Specification
|
 |
|
| FL-3091365
Mifepristone |
[84371-65-3]
(11ß,17ß)-11-[4-(Dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)
estra-4,9-dien-3-one
C29H35NO2
FW:429.60
Use: Abortifacient
Specification
|
 |
| FL-3091398
Mycophenolate Mofetil |
[128794-94-5]
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,
2-(4-morpholinyl)ethyl ester
C23H31NO7
FW 433.49
Use: Immunosuppressant
Specification
|
 |
|
|
| FL-
Mycophenolate Sodium |
[37415-62-6]
Use: Immunosuppressant
Specification (available on request)
|
 |
|
| FL-3088174
Nonivamide |
[2444-46-4]
N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-nonanamide, >98%
C17H27NO3
FW 293.40
Use: Rodent or insect repellent, Lacrimator, Food seasoning
Specification
|
 |
|
|
Notice: Please be reminded that some products listed above are
still patented and can only be made available for R & D
use as permitted under 35 USC 271 (e) (1). We will not be responsible
if the use of any of the above products infringes on any patent
in your country. |
|